Tag: AlphaMedix™

AlphaMedixTM Proves Effective in Treating Neuroendocrine Tumors

Phase 2 results show AlphaMedix hit primary goals with strong responses and tolerability in GEP-NETs, underscoring 212Pb targeted alpha therapy’s…

Innovation

AlphaMedix™ Excels in Phase 2 Study for GEP-NETs

AlphaMedix™ achieved major success in a phase 2 GEP-NET cancer trial, marking a breakthrough in targeted alpha therapy for advanced…

Drugs & Medications